Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Itolizumab

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Equillium announces Phase 3 study results for Itolizumab in GVHD
    Equillium announces Phase 3 study results for Itolizumab in GVHD

    27 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250327334273/en/Equillium-Announces-Results-of-the-Phase-3-EQUATOR-Study-of-Itolizumab-in-First-Line-Treatment-of-Patients-with-Acute-Graft-Versus-Host-Disease

    BUSINESSWIRE
    27 Mar 2025
    Share Share
    Equillium Reports Positive Phase 2 Data for Itolizumab in UC
    Equillium Reports Positive Phase 2 Data for Itolizumab in UC

    06 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250206241338/en

    BUSINESSWIRE
    06 Feb 2025
    Share Share
    Equillium Announces Interim EQUATOR GVHD Enrollment Achieved
    Equillium Announces Interim EQUATOR GVHD Enrollment Achieved

    14 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240514537675/en

    BUSINESSWIRE
    14 May 2024
    Share Share
    Equillium Announces Positive Data from the Ph 1b EQUALISE study
    Equillium Announces Positive Data from the Ph 1b EQUALISE study

    01 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240401373328/en

    BUSINESSWIRE
    01 Apr 2024
    Share Share
    Equillium delivers new lupus data to Ono's doorstep
    Equillium delivers new lupus data to Ono's doorstep

    01 Apr 2024

    // Max Bayer FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/equlliums-lupus-candidate-delivers-new-data-teeing-opt-decision-ono

    Max Bayer FIERCE BIOTECH
    01 Apr 2024
    Share Share
    Biocon starts clinical study to evaluate efficacy of Itolizumab
    Biocon starts clinical study to evaluate efficacy of Itolizumab

    15 Dec 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-starts-clinical-study-to-evaluate-efficacy-of-itolizumab/articleshow/96243936.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    15 Dec 2022
    Share Share